20 Dec 2023
According to research published in JAMA, tirzepatide treatment for adults with obesity sees some success in maintaining weight loss. The study saw patients who received 36 weeks of treatment maintaining weight loss after treatment ended for 88 weeks, though continued treatment is necessary to maintain improvements.
Study links premature ovarian insufficiency (POI) to risk of mortality
17 May 2024
Cardiovascular disease mortality associated with low testosterone in men
17 May 2024
People with obesity using semaglutide see cardiovascular improvements
17 May 2024
Men with obesity lose more weight with cash incentives, research says
17 May 2024
Research Assistant in Endocrinology (University of Sheffield)
14 May 2024